Health & Biotech
Which ASX health companies are making strides in world’s largest healthcare market?
Check Up: Diet Coke put on notice as WHO labels artificial sweetener aspartame ‘possibly carcinogenic’
ASX Health Stocks: US FDA happy to review anal fissure drug; gives green light to Clarity’s Phase 3 trial
PharmAust’s preliminary trial data indicate slowing or stopping the progression of motor neuron loss that causes MND
MGC Pharma welcomes Australia’s reclassification of psychedelic compounds
Dimerix’s Phase 3 FSGS kidney disease trial appropriate for key China market
ASX Health Stocks: Lumos soars 327pc after US FDA approval for aid to detect bacterial respiratory infections
Melodiol’s Health House International delivers strong financial result to validate growth strategy
Just what the doctor ordered for Bioxyne’s Dr Watson brand
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
Wellnex expands supply agreement with Haleon to sell paracetamol products in UK, Ireland and UAE
ASX Health Stocks: Ramsay Healthcare up 7pc as its looks to sell joint Asian Venture
Incannex confident in upcoming pivotal study of IHL-42X drug into obstructive sleep apnoea
ASX Health stocks: INOVIQ soars 44pc on clinical data for breast cancer test
PharmAust gives patients in Motor Neurone Disease clinical trial escalated dose ahead of Phase-2
ASX Health Stocks: Silk Laser gives thumbs up to $180 million Wesfarmers bid, soars 18%
ScoPo’s (actually Wilkie’s) Powerplays: ASX health stocks up as Avita Medical gets US FDA green light
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
